Abstract:Precise imaging-guided therapy of a pulmonary metastasis tumor is of great significance for tumor management and prognosis. Persistent luminescence nanoparticles (PLNPs) are promising probes due to their in situ excitation-free and low-background imaging characteristics. However, most of the PLNP-based probes cannot intelligently distinguish between normal and tumor tissues or balance the needs of targeted accumulation and rapid metabolism, resulting in false positive signals and potential side effects. Besides, the luminescence intensity of single-emissive PLNPs is affected by external factors. Herein, we report a self-evolving double-emissive PLNP-based nanoprobe ZGMC@ZGC-TAT for pulmonary metastatic tumor imaging and therapy. Acid-degradable green-emitting PLNPs (ZGMC) with good afterglow performance and therapeutic potential are synthesized by systematic optimization of dopants. Ultra-small red-emitting PLNPs (ZGC) are then prepared as imaging and reference probes. The two PLNPs are finally covalently coupled and further modified with a cell-penetrating peptide (TAT) to obtain ZGMC@ZGC-TAT. Dual emission ensures a stable luminescence ratio (I700/I537) independent of probe concentration, test voltage and time gate. ZGMC degrades and phosphorescence disappears in a tumor microenvironment (TME), resulting in an increase in I700/I537, thus enabling tumor-specific ratiometric imaging. Cu2+ and Mn2+ released by ZGMC degradation achieve GSH depletion and enhance CDT, effectively inhibiting tumor cell proliferation. Meanwhile, the size of ZGMC@ZGC-TAT decreases sharply, and the resulting ZGC-TAT further causes nuclear pyknosis and quickly clear metabolism. The developed ZGMC@ZGC-TAT turns non-targeted lung aggregation of nanomaterials into a unique advantage, and integrates TME-triggered phosphorescence and size self-evolution, and on-demand therapeutic functions, showing outstanding prospects in precise imaging and efficient treatment of pulmonary metastatic tumors.

Detection of Lymph Node Metastasis with Near-Infrared Upconversion Luminescent Nanoprobes

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

Near-infrared Upconversion Multimodal Nanoparticles for Targeted Radionuclide Therapy of Breast Cancer Lymphatic Metastases

Development of a rare earth nanoprobe enables in vivo real-time detection of sentinel lymph node metastasis of breast cancer using NIR-IIb imaging

177Lu-Labeled Near-infrared Upconversion Nanoparticles for targeted theranostics of Breast Cancer Lymphatic Metastases

Dual-targeting Lanthanide-Icg-mof Nanoplatform for Cancer Theranostics: NIR II Luminescence Imaging Guided Sentinel Lymph Nodes Surgical Navigation

Real-time detection and resection of sentinel lymph node metastasis in breast cancer through a rare earth nanoprobe based NIR-IIb fluorescence imaging

Dual‐Targeting Peptides RGD10‐NGR9‐Conjugated Lanthanide Nanoparticle@Polydopamine As Upconversion Nanoprobes for in Vivo Imaging of Lung Cancer

Ultrasensitive in Vivo Detection of Primary Gastric Tumor and Lymphatic Metastasis Using Upconversion Nanoparticles.

Magnetic/Upconversion Fluorescent Nagdf4:Yb,Er Nanoparticle-Based Dual-Modal Molecular Probes for Imaging Tiny Tumors in Vivo

A Dual-Modal Magnetic Nanoparticle Probe for Preoperative and Intraoperative Mapping of Sentinel Lymph Nodes by Magnetic Resonance and Near Infrared Fluorescence Imaging

Multifunctional Gold Nanoclusters for Effective Targeting, Near-Infrared Fluorescence Imaging, Diagnosis, and Treatment of Cancer Lymphatic Metastasis

Multiplexed NIR-II Probes for Lymph Node-Invaded Cancer Detection and Imaging-Guided Surgery.

Sequential SPECT and NIR-II Imaging of Tumor and Sentinel Lymph Node Metastasis for Diagnosis and Image-Guided Surgery.

Ultra-Sensitive Detection and Inhibition of the Metastasis of Breast Cancer Cells to Adjacent Lymph Nodes and Distant Organs by Using Long-Persistent Luminescence Nanoparticles.

Self-evolving persistent luminescence nanoprobes for autofluorescence-free ratiometric imaging and on-demand enhanced chemodynamic therapy of pulmonary metastatic tumors

Specific diagnosis of lymph node micrometastasis in breast cancer by targeting activatable near-infrared fluorescence imaging

Core-shell Lanthanide Upconversion Nanophosphors As Four-Modal Probes for Tumor Angiogenesis Imaging.

Spatiotemporal Mapping of Lymphatic Metastases in Gastric Cancer Using Tumor-Trackable and Enzyme-Activatable Near-Infrared Fluorescent Nanoprobes

Synchronous Enhancement of Upconversion and NIR-IIb Photoluminescence of Rare-Earth Nanoprobes for Theranostics

Long-term Multimodal Imaging of Tumor Draining Sentinel Lymph Nodes Using Mesoporous Silica-Based Nanoprobes.